Kenji Negoro

This inventor holds 17 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Organic Chemistry. Top assignees: Astellas Pharma Gmbh, Tdk Corporation, California Institute of Technology. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Negoro. Retrieved from https://idiyas.com/inventor/kenji-negoro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 8)

% Patents Active = 52.9

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Tsukuba, JP (2007)
Ibaraki, JP (2003 - 2020)
Tokyo, JP (2009 - 2024)

Company Filing History:

California Institute of Technology

patents

4. 2 out of 329

Yamanouchi Pharmaceutical Company Ltd.

Tenvie Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Pyridazine Compound

Power Conversion

Thiazole Derivative

Aryl Alkynamide

Current Detection

Benzene Derivative

Isoquinoline Compounds

Oxadiazolidinedione

Pyrimidine Derivative

Fluoropyrrolidine

Coil Structure

Thiazolobenzoimidazole

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741942 - Substituted pyridazine compound (2026-09-22),

2. 12706541 - Electric power conversion apparatus and electric power conversion system (2026-08-11),

3. 12131859 - Coil structure (2024-10-29),

4. 11912679 - Aryl alkynamide derivatives (2024-02-27),

5. 11646667 - Current detection circuit, power conversion device, and power system (2023-05-09),

6. RE49111 - 2-acylaminothiazole derivative or salt thereof (2022-06-20),

7. 10781213 - Methods for preparing bis-tetrahydroisoquinoline-containing compounds (2020-09-22),

8. 10526334 - Methods for preparing bis-tetrahydroisoquinoline-containing compounds (2020-01-07),

9. 9951060 - 2-acylaminothiazole derivative or salt thereof (2018-04-24),

10. 9844549 - 2-aminothiazole derivative or salt thereof (2017-12-19),

11. 9562044 - 2-acylaminothiazole derivative or salt thereof (2017-02-07),

12. 8022208 - Benzene derivative or salt thereof (2011-09-20),

13. 7968552 - Oxadiazolidinedione compound (2011-06-28),

14. 7947690 - Pyrimidine derivative condensed with a non-aromatic ring (2011-05-24),

15. 7557112 - Aromatic-ring-fused pyrimidine derivative (2009-07-07),

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I'll be delighted to help you craft an article about inventor Kenji Negoro. Let's dive into his extraordinary journey and remarkable contributions to the field of technology.

Title: The Visionary Work of Kenji Negoro: Pioneering Technological Advancements

Introduction:

Kenji Negoro, a distinguished inventor based in Tokyo, JP, is renowned for his unwavering dedication to innovation and pursuit of excellence. With a remarkable portfolio of 14 patents, Negoro has solidified his reputation as a visionary whose work continues to inspire and shape the future of technology.

Latest Patents:

Negoro's latest patents include groundbreaking inventions such as Aryl alkynamide derivatives, which serve as potent STING inhibitors. These derivatives have shown promising results in treating autoimmune diseases, neurodegenerative diseases, type I interferonopathies, and other STING-mediated conditions. Additionally, his work on current detection circuits, power conversion devices, and power systems showcases his versatility and ingenuity in various technological domains.

Career Highlights:

Throughout his illustrious career, Negoro has made significant contributions to companies such as Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd. His innovative solutions and cutting-edge research have not only pushed the boundaries of technology but have also paved the way for transformative advancements in the pharmaceutical and healthcare industries.

Collaborations:

Negoro has collaborated closely with esteemed professionals in the field, including coworkers Taisuke Takahashi and Hiroaki Tanaka. Together, they have leveraged their expertise and collective ingenuity to tackle complex challenges and drive innovation forward.

Conclusion:

In conclusion, Kenji Negoro's passion for innovation and relentless pursuit of excellence have positioned him as a trailblazer in the world of technology. His visionary inventions and groundbreaking research continue to have a profound impact on shaping the future of healthcare, pharmaceuticals, and beyond. Negoro's dedication to pushing the boundaries of what is possible serves as a testament to his unwavering commitment to driving progress and making a lasting difference in the world of inventions.

Profile summary based on public USPTO records.